1. Volume 379, Issue 9812, Pages 229-235 (January 2012)
Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial 
Prof Fang Gao Smith, MD, Prof Gavin D Perkins, MD, Simon Gates, PhD, Duncan Young, MD, Prof Daniel F McAuley, MD, William Tunnicliffe, FRCP, Zahid Khan, FRCA, Prof Sarah E Lamb, DPhil 
The Lancet 
Volume 379, Issue 9812, Pages (January 2012)
DOI: /S (11)
Copyright © 2012 Elsevier Ltd Terms and Conditions

2. Figure 1
Trial profile
The Lancet  , DOI: ( /S (11) )
Copyright © 2012 Elsevier Ltd Terms and Conditions

3. Figure 2 Kaplan-Meier curves for duration of infusions
Duration of salbutamol and placebo infusions from 28 days after randomisation. HR=hazard ratio.
The Lancet  , DOI: ( /S (11) )
Copyright © 2012 Elsevier Ltd Terms and Conditions

4. Figure 3 Kaplan-Meier curves for mortality
Rate of death in the two study groups up to 28 days after randomisation.
The Lancet  , DOI: ( /S (11) )
Copyright © 2012 Elsevier Ltd Terms and Conditions